| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 1,461,816 | 1,340,580 | 1,618,170 | 2,372,830 | | Cost of Revenue | 1,304,120 | 1,147,844 | 1,455,225 | 2,106,146 | | | Gross Profit | 157,696 | 192,736 | 162,945 | 266,684 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 174,834 | 169,974 | 172,884 | 153,510 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (17,138) | 22,762 | (9,939) | 113,174 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (17,138) | 22,762 | (9,939) | 113,174 | | Interest Expense | 14,688 | 18,464 | 17,763 | 26,083 | | Income Before Tax | (31,826) | 4,298 | (27,702) | 87,091 | | Income Tax Expense | (40,381) | 15,341 | 7,008 | 30,766 | | Minority Interest | 63 | 370 | 163 | (46) | | | | Net Income From Continuing Ops | 8,618 | (10,673) | (34,547) | 56,279 | | | Non-recurring Events | | Discontinued Operations | (1,438) | (2,404) | (760) | 5,727 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,180 | (13,077) | (35,307) | 62,006 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,180 | ($13,077) | ($35,307) | $62,006 |
|
0.26% Nasdaq 
0.20 (1.20%) 
Income Statement
